相关实验视频
Updated: Jan 14, 2026

08:46
A Neonatal Imaging Model of Gram-Negative Bacterial Sepsis
Published on: August 12, 2020
6.9K
[治疗新生儿尿血感染的临床药物治疗的进展]
Bei-Bo Cai1, Fei-Fei Chen1, Fang Luo1
1Department of Clinical Pharmacy, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China.
概括
新生儿的尿 (Ureaplasma urealyticum,UU) 可以导致严重的呼吸系统问题和发育问题. 本综述探讨了治疗新生儿UU感染的安全和有效的药物选择,因为没有标准治疗方法.
科学领域:
- 新生儿医学 新生儿医学
- 传染性疾病 传染性疾病
- 药理学 药理学是指药理学的学科.
背景情况:
- 尿性尿素 (Ureaplasma urealyticum,UU) 是新生儿呼吸道中常见的病原体.
- 从母亲到婴儿的垂直传播发生不论膜破裂或分娩方式.
- UU感染与早产,低出生体重,支气管肺功能障碍和神经发育障碍有关.
研究的目的:
- 审查新生儿Ureaplasma urealyticum感染的当前药物治疗选择.
- 为管理新生儿UU感染的临床实践提供指导.
- 为了解决缺乏标准化治疗方案的问题.
主要方法:
- 对新生儿Ureaplasma urealyticum治疗现有研究的文献综述.
- 对药理干预措施的分析,重点关注疗效和安全性.
- 综合数据以确定潜在的治疗策略.
主要成果:
- 目前,对于新生儿UU感染治疗,没有统一的标准治疗方案.
- 有各种各样的药理选择,每个都有特定的疗效和安全性考虑.
- 与未成熟的新生儿免疫和器官系统平衡治疗疗效至关重要.
结论:
- 新生儿UU感染的有效药理治疗需要仔细考虑安全性和疗效.
- 需要进一步的研究和共识,以建立标准化的治疗指南.
- 有信息的临床决策对于优化受影响新生儿的治疗结果至关重要.
更多相关视频
相关概念视频
Pharmacokinetics in Pediatric Patients: Drug Excretion
209
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
209
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
250
A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
250
Acute Pyelonephritis II: Diagnostic Studies and Management
308
Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
308
Urinary Tract Infection IV: Nursing Management
432
In managing urinary tract infections (UTIs) in nursing, a comprehensive assessment is essential. Begin by gathering subjective data, such as the patient’s complaints of dysuria (painful urination), urinary frequency, urgency, suprapubic pain, and any lower abdominal discomfort. This information can be complemented by questions regarding previous UTIs, sexual activity, and personal hygiene practices, which can provide insight into risk factors. Objective assessment should focus on signs...
432
Acute Pyelonephritis I: Introduction
475
Pyelonephritis is a bacterial infection that primarily affects the renal parenchyma and collecting system, including the renal pelvis, tubules, and interstitial tissue of one or both kidneys. It can be classified as either acute—a sudden, severe infection—or chronic, which refers to long-term or recurrent kidney infections.The primary cause of acute pyelonephritis (APN) is bacterial infection, with Escherichia coli accounting for approximately 70-80% of cases. Other bacteria, such...
475
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
241
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
241

